LT2525827T - Loratadino farmacinės kompozicijos, skirtos kapsuliavimui ir jų kombinacijos - Google Patents

Loratadino farmacinės kompozicijos, skirtos kapsuliavimui ir jų kombinacijos

Info

Publication number: LT2525827T
Authority: LT; Lithuania
Prior art keywords: loratadine; encapsulation; combinations; pharmaceutical formulations; formulations
Prior art date: 2010-01-19

Application number

LTEP11734280.8T

Other languages

English (en)

Inventor

Beth Okutan

Peter Draper

James Draper

Original Assignee

Catalent Ontario Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-01-19

Filing date

2011-01-18

Publication date

2021-03-25

2011-01-18 Application filed by Catalent Ontario Limited filed Critical Catalent Ontario Limited

2021-03-25 Publication of LT2525827T publication Critical patent/LT2525827T/lt

Links

238000005538 encapsulation Methods 0.000 title 1
JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 title 1
229960003088 loratadine Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

LTEP11734280.8T 2010-01-19 2011-01-18 Loratadino farmacinės kompozicijos, skirtos kapsuliavimui ir jų kombinacijos LT2525827T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA2690490A CA2690490C (en)	2010-01-19	2010-01-19	Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
PCT/CA2011/000052 WO2011088550A1 (en)	2010-01-19	2011-01-18	Pharmaceutical formulations of loratadine for encapsulation and combinations thereof

Publications (1)

Publication Number	Publication Date
LT2525827T true LT2525827T (lt)	2021-03-25

Family

ID=44303619

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP11734280.8T LT2525827T (lt)	2010-01-19	2011-01-18	Loratadino farmacinės kompozicijos, skirtos kapsuliavimui ir jų kombinacijos

Country Status (18)

Country	Link
US (1)	US20120301544A1 (lt)
EP (2)	EP2525827B1 (lt)
JP (1)	JP5328992B2 (lt)
AU (1)	AU2011207058B2 (lt)
CA (1)	CA2690490C (lt)
CY (1)	CY1123895T1 (lt)
DK (1)	DK2525827T3 (lt)
ES (1)	ES2843351T3 (lt)
HR (1)	HRP20201923T1 (lt)
HU (1)	HUE053412T2 (lt)
LT (1)	LT2525827T (lt)
MX (1)	MX344163B (lt)
PL (1)	PL2525827T3 (lt)
PT (1)	PT2525827T (lt)
RS (1)	RS61362B1 (lt)
SI (1)	SI2525827T1 (lt)
SM (1)	SMT202100026T1 (lt)
WO (1)	WO2011088550A1 (lt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3044472B2 (ja)	1990-07-13	2000-05-22	本田技研工業株式会社	好気性微生物の連続培養制御方法
CN103784446B (zh) *	2014-03-05	2016-01-06	大连金石滩药业有限公司	氯雷他定组合物
CN103784399B (zh) *	2014-03-05	2015-09-30	大连金石滩药业有限公司	氯雷他定液体组合物
JP7065562B2 (ja) *	2015-09-04	2022-05-12	ロート製薬株式会社	医薬組成物
KR101746500B1 (ko)	2016-05-26	2017-06-14	(주)알피바이오	연질캡슐 제제용 로라타딘 조성물 및 이를 함유하는 연질캡슐
US11607384B2 (en)	2017-12-08	2023-03-21	Western University Of Health Sciences	Lipid emulsified drug delivery systems for chemoprevention and treatment
US11911517B2 (en)	2018-05-16	2024-02-27	Bayer Healthcare Llc	High concentration suspension formulation for cold and flu soft gel capsule medications
CN112426404B (zh) *	2020-10-29	2023-02-28	太阳升(亳州)生物医药科技有限公司	用于制备富马酸卢帕他定口服液的方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4282233B1 (en)	1980-06-19	2000-09-05	Schering Corp	Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
WO1985003707A1 (en)	1984-02-15	1985-08-29	Schering Corporation	8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
GB8903804D0 (en) *	1989-02-20	1989-04-05	Sandoz Ltd	Improvements in or relating to organic compounds
US4900775A (en) *	1988-02-29	1990-02-13	Gaf Chemicals Corporation	Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone
US4910205A (en)	1988-05-02	1990-03-20	Schering Corporation	Transdermal delivery of loratadine
US4863931A (en)	1988-09-15	1989-09-05	Schering Corporation	Antihistaminic fluoro substituted benzocycloheptapyridines
US4990535A (en)	1989-05-03	1991-02-05	Schering Corporation	Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
ZA925581B (en) *	1991-07-26	1993-05-14	Smithkline Beecham Corp	Pharmaceutical microemulsions.
US5314697A (en)	1992-10-23	1994-05-24	Schering Corporation	Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
GB9226238D0 (en)	1992-12-16	1993-02-10	Scherer Ltd R P	Encapsulation apparatus and process
US6054136A (en) *	1993-09-30	2000-04-25	Gattefosse S.A.	Orally administrable composition capable of providing enhanced bioavailability when ingested
EP0741560A1 (en) *	1994-01-24	1996-11-13	The Procter & Gamble Company	Process for solubilizing difficultly soluble pharmaceutical actives
GB9405304D0 (en)	1994-03-16	1994-04-27	Scherer Ltd R P	Delivery systems for hydrophobic drugs
BR9507437A (pt) *	1994-04-07	1997-09-16	Smithkline Beecham Plc	Base livre de halofantrina e composições para o tratamento da malária
US5595997A (en)	1994-12-30	1997-01-21	Sepracor Inc.	Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
EP1049459B1 (en) *	1998-01-20	2009-04-22	Applied Analytical Industries, Inc.	Oral liquid compositions
US6132758A (en)	1998-06-01	2000-10-17	Schering Corporation	Stabilized antihistamine syrup
ES2226289T3 (es)	1998-06-30	2005-03-16	Pfizer Products Inc.	Loratadina para uso como antiarritmico.
US6221391B1 (en) *	1998-11-23	2001-04-24	Accucaps Industries Limited	Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
US20030235595A1 (en) *	1999-06-30	2003-12-25	Feng-Jing Chen	Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
US7115565B2 (en) *	2001-01-18	2006-10-03	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
WO2003000295A2 (en) *	2001-06-21	2003-01-03	Pfizer Products Inc.	Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors
US6720002B2 (en) *	2001-07-20	2004-04-13	R.P. Scherer Technologies, Inc.	Antihistamine formulations for soft capsule dosage forms
US7011846B2 (en) *	2001-12-21	2006-03-14	Shire Laboratories, Inc.	Oral capsule formulation with increased physical stability
US20040033257A1 (en) *	2002-05-30	2004-02-19	Strides Inc.	Pharmaceutical formulation in a drug delivery system and process for preparing the same
KR100533460B1 (ko) *	2002-07-20	2005-12-08	대화제약 주식회사	난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
WO2005123133A1 (en) *	2004-06-18	2005-12-29	Ranbaxy Laboratories Limited	A process for preparing ibuprofen soft gelatin capsules
MX2007006183A (es) *	2004-11-24	2007-09-11	Merck & Co Inc	Formulaciones farmaceuticas liquidas y semisolidas para administracion oral de una amida sustituida.
JP2008534591A (ja) *	2005-03-29	2008-08-28	マクニール−ピーピーシー・インコーポレーテツド	疎水性溶媒内に親水性薬剤を有する組成物
EP1961412A1 (en) *	2006-12-27	2008-08-27	LEK Pharmaceuticals D.D.	Self-microemulsifying drug delivery systems
US20110020440A1 (en) *	2007-11-19	2011-01-27	Cadila Pharmaceuticals Limited	Stable solutions of sparingly soluble actives

2010
- 2010-01-19 CA CA2690490A patent/CA2690490C/en active Active
2011
- 2011-01-18 ES ES11734280T patent/ES2843351T3/es active Active
- 2011-01-18 EP EP11734280.8A patent/EP2525827B1/en active Active
- 2011-01-18 RS RS20210013A patent/RS61362B1/sr unknown
- 2011-01-18 MX MX2012008301A patent/MX344163B/es active IP Right Grant
- 2011-01-18 PL PL11734280T patent/PL2525827T3/pl unknown
- 2011-01-18 SI SI201131943T patent/SI2525827T1/sl unknown
- 2011-01-18 US US13/574,189 patent/US20120301544A1/en active Pending
- 2011-01-18 JP JP2012549213A patent/JP5328992B2/ja not_active Expired - Fee Related
- 2011-01-18 DK DK11734280.8T patent/DK2525827T3/da active
- 2011-01-18 HU HUE11734280A patent/HUE053412T2/hu unknown
- 2011-01-18 SM SM20210026T patent/SMT202100026T1/it unknown
- 2011-01-18 EP EP19217776.4A patent/EP3653204A1/en active Pending
- 2011-01-18 WO PCT/CA2011/000052 patent/WO2011088550A1/en not_active Ceased
- 2011-01-18 LT LTEP11734280.8T patent/LT2525827T/lt unknown
- 2011-01-18 HR HRP20201923TT patent/HRP20201923T1/hr unknown
- 2011-01-18 PT PT117342808T patent/PT2525827T/pt unknown
- 2011-01-18 AU AU2011207058A patent/AU2011207058B2/en active Active
2021
- 2021-01-13 CY CY20211100020T patent/CY1123895T1/el unknown

Also Published As

Publication number	Publication date
HUE053412T2 (hu)	2021-06-28
CY1123895T1 (el)	2022-05-27
EP2525827A1 (en)	2012-11-28
CA2690490A1 (en)	2011-07-19
AU2011207058A1 (en)	2012-09-06
SMT202100026T1 (it)	2021-03-15
MX2012008301A (es)	2012-09-28
EP2525827B1 (en)	2020-11-18
SI2525827T1 (sl)	2021-02-26
HRP20201923T1 (hr)	2021-02-05
ES2843351T3 (es)	2021-07-16
US20120301544A1 (en)	2012-11-29
RS61362B1 (sr)	2021-02-26
EP3653204A1 (en)	2020-05-20
CA2690490C (en)	2012-06-26
PL2525827T3 (pl)	2021-05-04
EP2525827A4 (en)	2014-04-30
JP2013517303A (ja)	2013-05-16
MX344163B (es)	2016-12-07
PT2525827T (pt)	2021-01-20
DK2525827T3 (da)	2020-12-14
WO2011088550A1 (en)	2011-07-28
JP5328992B2 (ja)	2013-10-30
AU2011207058B2 (en)	2015-04-23

Publication	Publication Date	Title
IL253870B (en)	2018-05-31	Certain amino-pyrimidines and pharmaceutical preparations containing them
ZA201208265B (en)	2013-07-31	Pharmaceutical compositions and methods of making same
EP2395975A4 (en)	2013-05-22	ORAL PHARMACEUTICAL COMPOSITION OF DUTASTERIDE
PL3178472T3 (pl)	2022-02-14	Doustne preparaty metylonaltreksonu
GB2478849A8 (en)	2012-06-20	Improved pharmaceutical compositions and methods of delivery
HUE055771T2 (hu)	2021-12-28	Naproxén gyógyászati kiszerelései lágy gél kapszulázáshoz, és ezek kombinációi
GB201302653D0 (en)	2013-04-03	Pharmaceutical compositions and methods of treatment
IL221742A (en)	2015-09-24	Oral Pharmaceuticals Containing Debigtran Etxylate
GB2486567B (en)	2014-09-10	Pharmaceutical formulation
LT2525827T (lt)	2021-03-25	Loratadino farmacinės kompozicijos, skirtos kapsuliavimui ir jų kombinacijos
PL2557943T3 (pl)	2018-10-31	Doustne weterynaryjne kompozycje farmaceutyczne i nutraceutyki
PL2536412T3 (pl)	2015-07-31	Wziewna kompozycja farmaceutyczna
IL224191A (en)	2016-03-31	Compositions of vitamin d and cmc epi-14 analogues
IL221501A (en)	2016-11-30	Medicinal product containing miramistine
PT2568970T (pt)	2019-02-11	Formulações farmacêuticas estáveis contendo um anti-histamínico
PT2597084T (pt)	2016-08-12	Derivado de n-hidroxiformamida e medicamento contendo o mesmo
PL2415463T3 (pl)	2016-06-30	Kompozycja lecznicza w postaci cząstek stałych
EP2529755A4 (en)	2014-04-16	PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION
EP2404588A4 (en)	2012-08-01	PACKAGING FOR SOLID PHARMACEUTICAL PREPARATION
GB201012047D0 (en)	2010-09-01	Pharmaceutical formulations
GB201012046D0 (en)	2010-09-01	Pharmaceutical formulations
GB201002451D0 (en)	2010-03-31	Pharmaceutical comopitions and devices
AP3434A (en)	2015-10-31	Semisolid pharmaceutical formulations
GB201110598D0 (en)	2011-08-03	Pharmaceutical compositions and devices
GB201001335D0 (en)	2010-03-17	Drug release formulations